#Flash: Study finds, Diflluprednate Effective for the treatm
A Study was conducted to describe the effectiveness and side effect profile of difluprednate therapy in a series of patients with anterior scleritis. 25 patients(35 eyes) were analyzed in the study. 83% of eyes achieved resolution of scleritis, with a median time of resolution of 6 weeks. Eyes treated with an initial dose of more than 4 times daily were more likely to achieve disease resolution. Conclusively, Difluprednate alone may effectively treat non-infectious anterior scleritis with a tolerable side effect profile.

If you find this research insightful, please like, comment and share.

Source: https://www.ajo.com/article/S0002-9394(21)00465-7/fulltext?rss=yes